Medical Device Clinical Evaluation Guide: Steps, Requirements, and Best Practices
A medical device clinical evaluation is an important part of demonstrating the clinical safety and performance of a medical device. It involves systematically collecting, analyzing, and assessing relevant clinical evidence to determine whether the device meets applicable safety and performance requirements.
A well-prepared Clinical Evaluation Report (CER) documents the evaluation process, the evidence reviewed, and the conclusions reached about the device's clinical safety and performance.
What Is a Medical Device Clinical Evaluation?
A medical device clinical evaluation is a structured assessment of clinical data and other relevant evidence related to a medical device. It considers whether the available evidence adequately supports the device's intended purpose, safety, performance, and clinical benefits.
The evaluation should be appropriate to the device, its intended use, associated risks, and available clinical evidence. The findings are documented in the Clinical Evaluation Report, which provides a consolidated record of the evaluation and its conclusions.
Why Clinical Evaluation Is Essential for Medical Device Compliance
Clinical evaluation helps manufacturers demonstrate that their device performs as intended and that its benefits and risks have been appropriately assessed.
It also provides a documented basis for supporting regulatory compliance and identifying areas where additional clinical evidence may be required. A robust evaluation can therefore support both the initial regulatory submission and ongoing monitoring of the device throughout its lifecycle.
Medical Device Clinical Evaluation Guide: Key Steps in the Process
1. Define the Clinical Evaluation Scope and Plan
The process begins by defining the scope and objectives of the clinical evaluation. This includes identifying the device, its intended purpose, relevant clinical claims, applicable requirements, and the type of evidence that needs to be assessed.
A clear evaluation plan helps ensure that relevant clinical questions are addressed systematically.
2. Collect and Assess Clinical Evidence
The manufacturer collects relevant clinical evidence from appropriate sources. This may include clinical investigation data, scientific literature, post-market data, and information relating to equivalent or similar devices where applicable.
The evidence should be assessed for its relevance, quality, and suitability for supporting the clinical evaluation.
3. Analyze Clinical Data and Demonstrate Safety & Performance
The collected evidence is analyzed to determine whether it adequately supports the safety and performance of the device.
The assessment should consider the identified risks, clinical benefits, intended purpose, and relevant clinical claims. Any limitations or evidence gaps should also be identified and addressed where necessary.
4. Prepare the Clinical Evaluation Report (CER)
The findings of the evaluation are documented in the Clinical Evaluation Report (CER). The report should clearly describe the methodology used, evidence considered, analysis performed, and conclusions reached.
The CER should provide a clear link between the available clinical evidence and the conclusions regarding the device's clinical safety and performance.
EU MDR Requirements for Clinical Evaluation Reports (CER)
Under the EU Medical Device Regulation (EU MDR), clinical evaluation is an important component of demonstrating conformity for medical devices. Manufacturers are expected to establish and maintain a clinical evaluation based on relevant clinical evidence.
The CER EU MDR documentation should reflect the device's intended purpose, clinical claims, risks, benefits, and available evidence. The evaluation should be proportionate to the nature, classification, and characteristics of the device.
Manufacturers should also ensure that the clinical evaluation remains current as new clinical information becomes available.
Clinical Evidence Sources for Medical Device Evaluation
Clinical evidence can come from multiple sources depending on the device and the regulatory requirements applicable to it.
Sources may include clinical investigations, scientific literature, post-market surveillance data, registry information, and relevant data from comparable devices where appropriate.
Each source should be critically assessed for its relevance, reliability, and ability to support the specific clinical conclusions being made.
Common Challenges in Medical Device Clinical Evaluation
Manufacturers may face challenges when determining whether available evidence is sufficient to support the device's intended purpose and clinical claims.
Common difficulties include limited clinical data, inconsistent literature findings, insufficient evidence for specific claims, and difficulty determining the relevance of data from similar or equivalent devices.
Another challenge is maintaining consistency between the CER, risk management documentation, labeling, and other technical documentation.
Maintaining Clinical Evaluation Throughout the Device Lifecycle
Clinical evaluation is not necessarily a one-time activity completed before placing a device on the market. Manufacturers should continue to review relevant clinical information as the device progresses through its lifecycle.
New information from post-market surveillance, clinical investigations, scientific literature, complaints, and other sources may affect the conclusions of the existing evaluation.
Regular review and updating of the clinical evaluation report can help ensure that it continues to reflect the current safety and performance profile of the device.
Best Practices for Accurate FDA Medical Device Classification
Accurate FDA medical device classification starts with clearly defining the device's intended use, indications for use, and applicable claims. The classification should then be supported by the relevant FDA regulation, product code, and available information on similar legally marketed devices.
Intended Use
Intended use describes the purpose for which the device is designed or intended to be used. It is one of the key factors FDA considers when determining the appropriate classification of a medical device.
The intended use should be clearly defined and consistent across the device's labeling, regulatory documentation, and marketing claims.
Indications for Use
Indications for use provide more specific information about the disease, condition, patient population, or purpose for which the device is intended.
Even when two devices have similar technology, differences in their indications for use may affect their classification and regulatory pathway.
Product Code
A product code is a three-character identifier used by FDA to identify a generic category of medical devices. It is linked to the device's classification and applicable regulatory information.
Manufacturers can search FDA's Product Classification Database using device names, product codes, regulation numbers, or other available information.
Classification Regulation Number
The classification regulation number identifies the applicable regulation in Title 21 of the Code of Federal Regulations (21 CFR). FDA classification regulations are generally organized under 21 CFR Parts 862–892 according to medical specialty panels.
Confirming the regulation number helps establish the device type, applicable classification, and associated regulatory requirements.
Predicate Devices
For devices using the 510(k) pathway, identifying an appropriate predicate device is an important part of the regulatory assessment. A predicate is a legally marketed device used to support a claim of substantial equivalence.
The comparison should consider factors such as intended use, technological characteristics, and applicable performance or safety considerations.
510(k) Submission
The device classification and applicable regulatory controls help determine the appropriate premarket pathway. Many non-exempt Class II devices are subject to 510(k) requirements, while some Class I devices are exempt from premarket notification.
For Class III devices, Premarket Approval (PMA) is generally required unless another applicable regulatory pathway or exception applies.
Key Takeaways
FDA medical device classification is primarily risk-based and determines the level of regulatory control applicable to a device. Manufacturers should begin with the device's intended use and indications for use, then identify the relevant classification regulation, product code, and regulatory pathway.
A structured classification assessment can help reduce uncertainty and ensure that the device's regulatory strategy is aligned with FDA requirements.
FAQs about US FDA Medical Device Classification
1. What are the three FDA medical device classes?
FDA classifies medical devices into Class I, Class II, and Class III based on the level of regulatory control needed to provide reasonable assurance of safety and effectiveness. Class I generally represents the lowest level of risk and regulatory control, while Class III is subject to the highest level of regulatory control.
2. What is the difference between Class I, Class II, and Class III medical devices?
Class I devices are generally subject to General Controls. Class II devices are generally subject to General Controls and Special Controls, while Class III devices are generally subject to General Controls and Premarket Approval (PMA) requirements. Specific requirements can vary depending on the device and applicable exemptions.
3. What is a Product Code in FDA medical device classification?
An FDA Product Code is a three-character identifier associated with a generic category of medical devices. It helps FDA identify and track devices and is connected to the applicable classification and regulatory information.
4. What is the purpose of the 513(g) pathway?
A 513(g) request allows a manufacturer or other requester to obtain FDA's views regarding the classification of a particular device and the regulatory requirements that may apply. FDA's response can address the applicable device type, classification, and whether a PMA, 510(k), or neither may be required based on the information submitted.
5. What is a predicate device, and why is it important?
A predicate device is a legally marketed device used as a comparison when pursuing the 510(k) pathway. The manufacturer uses the predicate to support a determination of substantial equivalence between the new device and the legally marketed device.